Table 3.
Competing risks regression model to evaluate for predictive variables of intracranial hemorrhage, with death and kidney transplant as competing risks
| Variables | Adjusted subhazard ratio | P-value | 95% Confidence interval |
|---|---|---|---|
| ADPKD (vs. non-ADPKD) |
2.97 |
<0.001 |
2.27-3.89 |
| Age at start of dialysis |
0.98 |
<0.001 |
0.98-0.99 |
| Gender (male vs. female) |
0.99 |
0.952 |
0.89-1.11 |
| Race (AA vs. non-AA) |
1.29 |
<0.001 |
1.14-1.46 |
| Hemodialysis vs peritoneal dialysis |
1.64 |
<0.001 |
1.29-2.07 |
| Year of starting dialysis (vs more recent year) |
1.39 |
<0.001 |
1.36-1.42 |
| Diabetes mellitus |
0.76 |
<0.001 |
0.68-0.85 |
| COPD |
0.66 |
<0.001 |
0.54-0.82 |
| Hypertension |
1.23 |
0.008 |
1.06-1.43 |
| Congestive heart failure |
0.79 |
<0.001 |
0.69-0.89 |
| Atherosclerotic heart disease |
0.93 |
0.275 |
0.81-1.06 |
| Peripheral vascular disease |
0.85 |
0.053 |
0.72-1.00 |
| Tobacco use |
0.78 |
0.079 |
0.59-1.03 |
| Alcohol dependence |
0.89 |
0.679 |
0.50-1.58 |
| Serum albumin < 3gm/dL |
0.93 |
0.326 |
0.80-1.08 |
| BMI < 20 kg/m2 | 0.80 | 0.091 | 0.63-1.04 |
ADPKD: autosomal dominant polycystic kidney disease; AA: African-American; COPD: chronic obstructive pulmonary disease; BMI: body mass index.